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表明 K425 侧边氨基酸的突变对 bbGcn5 的自乙酰化程度几乎没有影响。最后，
我们尝试解析出 bbGcn5 的晶体结构。我们成功获得了 bbGcn5 的晶体和高分辨
率的 X 射线衍射数据。然而，通过蛋白质质谱分析实验，我们发现这些晶体实





















Lysine acetylation is one of very important posttranslational modifications in proteins, 
including histones. It regulates gene transcription, cell cycle, apoptosis and 
development, and plays a role in tumorigenesis, memory and energy metabolism. 
PCAF (p300/CBP associated factor) and Gcn5 (General control nonderepressible-5) 
are histone acetyltransferases in GNAT (Gcn5-related N-acetyltransferase) family, 
which have a conserved catalytic domain so called HAT (histone acetyltransferase). 
PCAF/Gcn5 mainly accumulate in nucleus, which is controlled by their 
autoacetylation state in a conserved region adjacent to the HAT domain. However, 
whether autoacetylation is conserved in other Gcn5 homologues is not known. We 
cloned a Gcn5 homologue from Branchiostomid (bbGcn5) and successfully expressed 
in E. coli a fragment (399-662) that contains a HAT domain and adjacent conserved 
region. We found that the same autoacetylation phenomenon has occurred in vitro 
using the purified bbGcn5 protein. Interestingly, our further mutagenesis identified a 
key acetylation site K425 and partial acetylation site K422, which are contradicted 
with those reported in current literature. In order to understand the mechanism of 
site-specific autoacetylation, we tested three hypotheses. First hypothesis is that 
acetylation sites are determined by any specific interactions between Gcn5(399-472) 
and Gcn5(471-662). We expressed both these fragments in different tags and 
performed reciprocal pulldown experiments. Unfortunately, no interaction could be 
detected. Second hypothesis is that the amino acids sequences around lysine sites 
might form a specific site for HAT recognition. However, mutation of a series of 
characteristic residues flanking the lysine did not seem to change autoacetylation 
states of bbGcn5. Lastly, we attempted to solve the crystal structure of bbGcn5. We 
successfully obtained its crystals and the high-resolution data. However, we found the 
crystal only contains partial bbGcn5 fragment, only N terminal part of HAT domain 
identified using mass spectrometric analysis. Together, we discovered a site-specific 
autoacetylation in bbGcn5. Although we have not been able to find molecular bases 
















how PCAF/Gcn5 autoacetylation regulates their nuclear localization in vivo. 
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体如表格 1所示。  
 
表格 1核心组蛋白修饰与功能[6, 7] 








H2A S1 磷酸化 MSK1 抑制基因转录  
K5 乙酰化 p300 激活基因转录  
K11
9 
泛素化 hPRC1L 参与 ploycomb
沉默 
 
H2B K5 乙酰化 p300 激活基因转录  
K12 乙酰化 p300 激活基因转录  
S14 磷酸化 Mst1 细胞凋亡，
DNA修复 
 
K15 乙酰化 p300 激活基因转录  
K20 乙酰化 p300 激活基因转录  





泛素化 Ubc2 调节 H3K4甲
基化 
 
















T3 磷酸化 Haspin 细胞分裂染色
体排列 
 




PHD / Chromo / 
WD40 / ADD 
R8 甲基化 PRMT5 调节细胞生长
和增生 
 




Chromo / PHD / Tudor 
/ WD40 





T11 磷酸化 DIK/ZIP 细胞分裂  




TandemPHD / Tandem 
Bromo 
R17 甲基化 CARM1 激活基因转录 Tudor 
K18 乙酰化 p300 激活基因转录  
K23 乙酰化 p300 激活基因转录 Chromo 
K27 甲基化 Eed - Ezh 2 X染色体失活 Chromo / WD40 





K36 甲基化 NSD1 基因转录的激
活 




H4 S1 磷酸化 CKII DNA损伤修复  
R3 甲基化 PRMT1 / 
PRMT5 
染色质的活化 Tudor / ADD 
K5 乙酰化 p300 激活基因转录 Bromo 




















K12 乙酰化 p300 激活基因转录  











小体上缠绕长约 146bp的 DNA（约 1.75圈）。核小体之间以 40至 60bp的 DNA




















































家族、核受体辅激活物和 TF IIIC家族，具体分类如表格 2所示。 
 
表格 2 HAT及其家族的特征[12] 
Table 2 Characteristics of known and putative HATs 











Hat1 从酵母到人 没有（B型 HAT） 是 H4 
Gcn5 从酵母到人 辅激活物（接头蛋白） 是 H3/H4 
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